[Study on Butylon, a new combined analgesic, with special reference to the analgesic potentiation between o-ethoxybenzamide and 3-hydroxy-p-burtyrophenetidide (Bucetin)].
D000311:Adrenal Glands / Q000032:analysis; D000700:Analgesics; D000818:Animals; D001205:Ascorbic Acid / Q000032:analysis; D002090:Butyrophenones / Q000494:pharmacology*; D002110:Caffeine / Q000494:pharmacology; D004357:Drug Synergism; D007035:Hypothermia; D051381:Rats; D012457:Salicylamides / Q000008:administration & dosage / Q000494:pharmacology* / Q000633:toxicity; D013831:Thiamine / Q000494:pharmacology
D000700:Analgesics; D002090:Butyrophenones; D012457:Salicylamides; D002110:Caffeine; D001205:Ascorbic Acid; D013831:Thiamine